Acquisition Announced Sponsor buyer Sponsor exit
THL Partners acquisition of Celerion
Announced Apr 2026
Advisers
Celerion
Target
Not disclosed
THL Partners
Acquirer
- Legal adviser
- Kirkland & Ellis

Team: Chris Elder, Jeremy Mandell, Ted Frankel, George Krug, Divya Gulati, Seffie Wilkinson, Nick Carreri, Derek Thomas, Dennis Williams, Brian King, Alexa Auger, Sehj Vather, Jeremy Miller, Dan Lewis, Kyla Risko, River Crane, Matt Antinossi, Caitlin Bradford, Mike Krasnovsky, Kelsie Harris, Cameron Bateman, Risa Salins, Kayla Garcia, Olivia Hunter, Rob Miceli, Henry Harper, Will Dunbar, Mike Saretsky, Jacob Manheim, Matt Reilly, Stephanie Greco, Matthew Sinclair-Thomson, Matt Wheatley, Chris Thomas, Aleksandra Katolik, Marta Levytska, John Kabealo, Bryan Applefeld, Anna Geml
Other advisers
- Financial adviser
- Target
- Celerion
- Acquirer
- THL Partners
- Seller
- H.I.G. Capital affiliate
- Target based in
- United States
- Buyer based in
- United States
- Seller based in
- United States
- Sector
- Pharma Services
- Tags
- Pharma Services, Clinical Trial Services, Life Sciences
In the league tables
Similar deals
- Everest Clinical Research acquisition of Firma Data Services Sep 2026 · Clinical Trial Services
- McKesson acquisition of Precision Medicine Group Aug 2026 · US$2.3bn · Clinical Trial Services
- SV Health Investors acquisition of EpiVax Apr 2026 · Pharma Services
- Webster Equity Partners acquisition of Lifecore Biomedical Sep 2026 · US$664m · Pharma Services
- Labcorp acquisition of MLM Medical Labs Sep 2026 · Clinical Trial Services
Sources
- Apr 2026 Kirkland Represents THL Partners on Majority Investment in Celerion kirkland.com
- 22 Apr 2026 THL Partners to Acquire Pharmaceutical Research Organization Celerion From H.I.G. Capital paulweiss.com
- 18 May 2026 Lazard: UNITED STATES H.I.G. Capital Announces the Sale of Celerion lazard.com

